Crossmark

Four years of clinical experience with Radium-223 for the treatment of castration-resistant prostate cancer

Crossref DOI link: https://doi.org/10.1016/j.remnie.2019.04.006

Published Print: 2019-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Álvarez Pérez, R.M.

García, A. Delgado

Martínez, S. García

Viedma, S. Sanz

Gerona, H. Palacios

Vinardel, M. Pajares

García, J. M. Jiménez-Hoyuela
License Information

Text and Data Mining valid from 2019-09-01
More Information

This article is maintained by: Elsevier

Article Title: Four years of clinical experience with Radium-223 for the treatment of castration-resistant prostate cancer

Journal Title: Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.remnie.2019.04.006

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.remn.2019.04.004

Content Type: article

Copyright: © 2019 Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. All rights reserved.